Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 273Thoracic 18Gynecologic 15Head & Neck 14Genitourinary 14Dermatologic 9Breast 9Sarcoma 5Other solid neoplasm 3Other neoplasm 3Lymphoid 3CNS 3Plasma cell 1Other hematologic neoplasm 1Other 1Myeloid 1Endocrine 1

Conditions

Obesity 298Mucositis 116Neoplasms 108Breast Neoplasms 87Overweight 80Sexual Dysfunction, Physiological 74Polycystic Ovary Syndrome 71Dyspnea 48Motor Activity 46Constipation 45Head and Neck Neoplasms 42Weight Loss 36Prostatic Neoplasms 32Pain 29Stomatitis 26Endometrial Neoplasms 23Opioid-Induced Constipation 21Multiple Endocrine Neoplasia Type 1 20Diabetes Mellitus 20Lung Neoplasms 18Colorectal Neoplasms 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Sexual Dysfunctions, Psychological 15Depression 15Cardiovascular Diseases 15Anxiety Disorders 15Sedentary Behavior 13Insulin Resistance 13Infertility 13Cancer-related Fatigue 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Adenocarcinoma Of Esophagus × Other × Clear all
NCT03813381 2023-10-16

CARE-PRO

Istituto Oncologico Veneto IRCCS

Phase NA Completed
160 enrolled
GastrointestinalOther

Adenocarcinoma Of Esophagus, Barrett Esophagus, Motor Activity, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡